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Objective: To investigate the effects of hepatic radiofrequency ablation (RFA)
in patients with malignant liver disease with respect to inflammation activation
and stress response.
Materials and Methods: In an observational trial, we investigated the physio-
logic parameters of 17 patients (20 interventions) who underwent percutaneous
RFA under general anesthesia after applying total intravenous anesthesia. TNFα ,
IL-6, IL-8, IL-10, adrenaline and noradrenaline, liver enzymes, lactate and crea-
tine kinase were determined pre-interventionally after induction of anesthesia
(T1), 90 minutes after initiation of RFA (T2), immediately after the conclusion of
the procedure (T3), and 24 hours after the procedure (T4).
Results: A significant increase in body temperature (p < 0.001), and mean
arterial pressure (p = 0.001) were measured intraoperatively (T2) and the day
after the procedure (T4). Increased levels of IL-6 were measured at T3 and T4 (p
= 0.001). IL-10 increased immediately after the procedure (T3; p = 0.007). IL-6
levels correlated well with the total energy applied (r = 0.837). Significant increas-
es in the levels of adrenaline and noradrenaline were present at T3 and T4 (p <
0.001). The RFA-induced destruction of hepatic tissue was associated with
increased levels of AST, ALT, GLDH and LDH. 
Conclusion: Percutaneous RFA of hepatic malignancies causes an inflamma-
tory and endocrine activation, similar to the systemic inflammatory response syn-
drome. These effects have to be taken in account when dealing with patients sus-
ceptible to sepsis or multi-organ failure.
ver the last two decades an increasing number of minimally invasive,
local ablative therapies have been established, challenging the role of
surgical resection (1). Radiofrequency ablation (RFA) in particular, has
increasingly been employed with promising results (2, 3). With the recent ablation
techniques, all regions of the liver can effectively be treated by RFA (4, 5).
The excessive cytokine release from performing the cryoablation is known to result
in multiorgan failure (6). Further frequently reported complications related to a
systemic inflammatory or stress response include acute renal and liver failure, as well
as acute respiratory distress syndrome (7, 8). When compared with cryotherapy,
hepatic RFA presents with a lower expression of tumor necrosis factor α (TNFα ) and
interleukin (IL)-1β(6). 
However, from previous studies on intraoperative RFA, contradictory results on
pro- and anti-inflammatory cytokines and systemic stress response have been reported
(9, 10). There are only a few, unsystematic data regarding the inflammatory response
after percutaneous RFA. These data suggest cytokines to play a role in post-ablation
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O
Case Study of Hepatic Radiofrequency
Ablation Causing a Systemic
Inflammatory Response Under Total
Intravenous Anesthesiahypoxemia (11). Cytokines are also speculated to influence
post-RFA coagulopathy and thrombopenia (12). The
currently available data, however, is not sufficient to come
up with robust recommendations for patient management
and we feel that more data on this issue is needed.
Therefore, the purpose of this prospective study was to
systematically investigate the effects of RFA on stress and
inflammation in patients undergoing percutaneous
treatment for hepatic tumors under general anesthesia with
total intravenous anesthesia (TIVA).
MATERIALS AND METHODS
From August 1 to 31, 2007 all patients scheduled for
percutaneous RFA for treatment of hepatic cancer or
metastases were recruited for this explorative prospective
cohort study. The investigative protocol was approved by
the Institutional Review Board and informed consent was
obtained from every patient before enrollment.
Demographics
Seventeen patients (M:F = 9:8; mean age, 61.5±11.7;
range, 38-78 years) treated by CT-guided RFA for non-
resectable hepatocellular carcinoma (HCC; n = 4) and liver
metastases from colorectal cancer (n = 7), breast cancer (n
= 3), gastric cancer (n = 1), uterine cancer (n = 1), and
leiomyosarcoma (n = 1) were included in this study.
Patients suffered from a variable number of lesions of
different sizes, with a total of 28 lesions treated in 20
treatment sessions. The general condition and anesthesia-
related risks were classified according to the American
Society of Anesthesiology (ASA) grading system (Table 1).
All patients with metastatic disease had undergone
resection of the primary tumor, and 14 patients had been
pre-treated, either by chemotherapy (n = 6), combined
surgical resection of liver metastases plus chemotherapy (n
= 3), or surgical resection of liver metastases without
chemotherapy (n = 5). None of the patients had undergone
systemic chemotherapy within four weeks prior to the
intervention.
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Table 1. Summary of Patient Characteristics, Radiofrequency-System and Applied Energy
Patient
Procedure Sex Age Weight ASA
Primary
No.
1 Tumor
Lesions Size (cm) Probe Energy (kJ)
01 01 F 75 80 2 CR 1 0.2×2 LeVeen 0226.2
02 02 M 60 80 2 CR 1 0.2×2.5 LeVeen 1281.6
03 03 M 49 70 2 CR 1 3.5×4 LeVeen 2202.2
04 04 F 38 67 2 B 3 0.3×3 LeVeen 1519.2
2.8×3 2.5×2
05 05 M 78 65 2 CR 1 0.2×1.8 LeVeen 1572.0
02 06 M 60 78 2 CR 2 0.3×2.5 LeVeen 0744.6
2.3×2.7
06 007 F 73 70 2 L 2 0.3×2.8 HiTT 1404.0
0.3×2.5
07 08 F 45 47 1 U 4 2.5×2 HiTT 1919.0
0.2×2
0.2×1.6
1.2×1
08 09 F 65 75 2 B 1 3.8×4 LeVeen 1556.4
09 10 F 61 62 2 CR 1 1.6×1.6 LeVeen 0511.2
10 11 M 69 100 3 HCC 1 3.2×3 LeVeen 0760.8
11 12 F 70 55 2 CR 1 0.2×1.5 LeVeen 1368.0
12 13 M 63 70 2 CR 1 0.4×3.5 LeVeen 0678.0
13 14 M 54 60 3 HCC 1 3.1×3 LeVeen -
14 15 M 69 78 2 HCC 1 0.2×2 LeVeen 1530.0
15 16 M 49 81 3 G 1 3.5×3.2 LeVeen -
08 17 F 65 75 2 B 1 0.3×2 LeVeen 0537.6
16 18 F 51 47 2 B 2 2.5×2.3 LeVeen 1590.0
0.2×1.8
17 19 M 77 64 2 HCC 1 4.5×3.3 LeVeen 0485.4
10 20 M 69 97 2 HCC 1 0.3×3 LeVeen 0369.0
Note.─
1 = Patients 2, 8 and 10 were treated twice, ASA = American Society of Anesthesiology, B = breast, CR = colorectal; G = gastric, HCC = 
hepatocellular carcinoma, L = leiomyosarcoma, No. =  number, U = uterusStudy Protocol
After informed consent had been obtained, patients were
enrolled 48 hours before the intervention. Inclusion criteria
included less than five metastatic or three HCC lesions per
lobe, a tumor size of less than 5 cm, and no extrahepatic
tumor (13). Exclusion criteria were portal vein thrombosis
and contraindications to percutaneous puncture, i.e.
ascites, or coagulopathy with an international normalized
ratio (INR) > 1.5 or a platelet count < 50,000 (10
9/l). 
After enrollment, patient vital signs, body temperature,
and blood samples were obtained. Four measurement time
points (T1-T4) were defined as follows: 
T1 = pre-interventionally after induction of anesthesia,
T2 = intra-interventionally, 90 min after initiation of
RFA,
T3 = post-interventionally after finishing the procedure,
and
T4 = post-interventionally the following day (22-24 h
after initiation of RFA).
Hemodynamic measurements, body temperature
(Infrared Ear-Thermometer, First Temp Genius
�,
Sherwood Medical, UK), and blood samples were obtained
at all time points T1-T4. All blood samples were immedi-
ately cooled down to 4� C and centrifuged. The plasma
fraction was separated, aliquoted, and stored at -70� C
until analysed.
Biochemical Analysis
Plasma samples were assayed by ELISA (Immulite 1000
�,
DPC Biermann, Bad Nauheim, Germany) for TNFα , IL-6,
IL-8, and IL-10. Serum samples for catecholamines
(adrenaline, noradrenaline) were stored on ice and
transferred to the laboratory for prompt high pressure
liquid chromatography (HPLC) analysis (Alliance HPLC
Systems, Waters Corporation, Milford, MA). Blood
samples for liver enzymes, creatine kinase (CK) and lactate
were taken at the same time.
Anesthesia Management
All procedures were performed under general anesthesia
according to our hospital routine protocol, including oral
premedication with 0.1 mg/kg midazolam (Midazolam
ratiopharm, Ratiopharm, Ulm, Germany) and monitoring
of ECG, invasive blood pressure, pulse oximetry, and
capnometry. Pre-oxygenation anesthesia was induced by
the injection of 0.1 mg/kg piritramide (Dipidolor
�, Janssen-
Cilag, Neuss, Germany), 1-2 mg/kg propofol (Propofol-
ratiopharm, Ratiopharm) and 0.2 mg/kg cisatracurium
(Nimbex
�, GlaxoSmithKline Uxbridge, UK). The patient’s
trachea was intubated and anesthesia was maintained
intravenously with 5-10 mg/kg/h propofol (Propofol-
ratiopharm, Ratiopharm) and 0.1-0.3 μ g/kg/min remifen-
tanil (Ultiva
�, GlaxoSmithKline). Patients were mechani-
cally ventilated (Servo 900C, Siemens Elema, Solna, SE),
in the volume controlled mode, with a tidal volume of 8
ml/kg and a respiratory rate to target an end-tidal partial
carbon dioxide pressure (EtCO2) of 34-40 mmHg. For
hemodynamic management, 2 ml/kg/h of Ringer’s solution
were infused. A foley catheter was placed in the bladder
(Ru ¨sch Sensor Silicon
�, Ru ¨sch, Belp, CH) to measure body
temperature and fluid balance. With removal of the RF
probe, the infusions of propofol and remifentanil were
discontinued. Upon emergence from anesthesia, the
patient was extubated and brought to the post-anesthetic
care unit until full recovery.
Radiofrequency Ablation Procedure
First, a standardized non-contrast CT (SOMATOM
Volume Zoom, Siemens, Forchheim, Germany) of the liver
was performed to visualize the lesion (4×2.5 mm, 120 kV,
150 mAseff). Next, the RF-probe was placed under CT-
guidance using 3 mm sequential images.
Two different generators, RF-3000 (Boston Scientific,
Natick, MA) and Elektrotom HiTT 106
� (Integra,
Plainboro, NJ) were used (Table 1). The probes used were
either mechanically expandable (LeVeen, Boston
Scientific, Natick, MA) or employed saline infusion (HiTT
needle electrode, Integra, Plainboro, NJ). The probe size
was individually adapted to the size of the lesion. Ablation
was performed according to the protocols recommended
by the vendors at two positions using the so called pull-
back technique (12, 14). At the end of the procedure, the
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Table 2. Summary of Clinical Parameters
T1 T2 T3 T4
Heart rate (bpm) 68.2 ± 14.8 69.6 ± 17.1 71.6 ± 13.6 84.3 ± 18.6
AB
MAP (mmHg) 77.9 ± 13.7
A91.9 ± 14.4
A 096.2 ± 13.3
A 96.1 ± 14.8
AB
Temperature (� C) 36.4 ± 0.50 37.8 ± 0.9
AC 36.2 ± 0.63 37.3 ± 0.9
AC0
Note.─
A = significant difference in comparison to, T1, 
B = significant difference in comparison to, T2, 
C = significant difference in 
comparison to, T3, MAP = mean arterial pressure
Changes in heart rate, mean arterial pressure, and temperature prior to ablation (T1), 90 minutes after Initiation of ablation procedure
(T2), immediately after conclusion of procedure (T3), and 24 hours after procedure (T4)probe was slowly withdrawn while tract ablation was
performed. In the RF-3000 system, the applied energy was
estimated as the product of time (s) and power (W), while
it was displayed on the HiTT106
� system.
Statistics
Data are presented as the mean and standard deviation.
A repeated measures ANOVA was performed to test for
differences. In case of significant results, a post hoc analysis
was performed using Scheffe’s procedure. A Pearson’s
correlation was used to determine a statistical relationship.
Statistical significance was forest a p < 0.05. All statistical
operations were performed using SPSS for Windows 17.0
(SPSS Inc, Chicago, IL). 
RESULTS
Stable TIVA was achieved in all patients and RFA was
successfully completed. Total procedure time and duration
of energy deposition were 152 ± 22 (113-186) minutes
and 101 ± 7 (92-112) minutes, respectively. There were
two major and one minor complication. In one patient, a
puncture-related hepatic artery bleeding was successfully
treated by transarterial coil embolization. Another patient
with previously known severe hepato-pulmonary
syndrome developed an intra-hepatic abscess and died
despite adequate percutaneous drainage 33 days after the
procedure from septic multi-organ failure. In one patient, a
fully reversible paresis of the right arm occurred, which
was due to the positioning of the arm above the head. In
two patients treated with the RF-3000 system, there was
no data for computing the amount of applied energy.
These patients were excluded from the correlation
analysis. The mean energy applied in the remaining
patients was 1125.3 ± 587.2 kJ.
Clinical Parameters
There were no significant changes in heart rate during
the interventions, but heart rate was significantly increased
on the first post-interventional day (p = 0.038). Mean
arterial blood pressure was significantly lower after
induction of anesthesia at T1, when compared to all other
points (p < 0.001). Body temperature increased signifi-
cantly during the procedure, but was normal again in the
post-anesthetic care unit. Temperature was again slightly
elevated on the first post-interventional day (p < 0.001)
(Table 2).
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Fig. 2. Graphic display of adrenaline (A) and noradrenaline (B) values over time. Plasma catecholamine levels peak at different times
after procedure, which may be due to anesthetic agents.
AB
Fig. 1. Over time, significant increase in pro-inflammatory IL-6
and delayed increase with rapid normalization of IL-10 was
observed.
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No significant changes could be detected for TNFα and
IL-8 levels. IL-6 increased during (T2; p > 0.05) and after
(T1 vs. T3; p = 0.003) the intervention and remained high
at the next day (T1 vs. T4; p = 0.001). IL-10 increased
significantly between T1-T3 (p = 0.007) and T2-T3 (p =
0.014), and started to decrease the following day (T4), but
remained above the pre-interventional level (p = 0.019)
(Fig. 1, Table 3). Post-interventional IL-6 levels strongly
correlated with the applied energy (r = 0.837, p = 0.01).
There was also a weak correlation between the plasma
levels of adrenaline and the anti-inflammatory cytokine IL-
10 after the intervention (r = 0.583, p = 0.022).
Catecholamine Levels
Post-interventional adrenaline levels were significantly
elevated in the recovery room (T1 vs. T3; p < 0.001), but
decreased to pre-interventional levels on the next day. In
contrast, noradrenaline was elevated on the first post-
interventional day only (p < 0.001) (Fig. 2, Table 3).
Serum Chemistry
Aspartate aminotransferase (AST) and alanine
aminotransferase (ALT) levels increased during the
procedure (p = 0.021), and continued to further increase
the next day (p < 0.001). Lactate dehydrogenase (LDH)
increase was delayed to the first post-interventional day (p
< 0.001). No significant changes could be demonstrated for
alkaline phosphatase (AP), pseudocholinesterase (PCHE),
and glutamate dehydrogenase (GLDH) levels. There was
an increase in CK, starting directly after the procedure (T1
vs. T4; p = 0.001). Lactate was slightly, but significantly
greater the day after the procedure (T4; p = 0.007) (Table
4).
DISCUSSION
This study demonstrated a persistent increase in pro-
inflammatory (IL-6) and a transient increase in anti-inflam-
matory cytokines (IL-10), with the increase in IL-6 being
correlated with the amount of applied energy. This
indicates a concomitant inflammatory response beyond
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Table 3. Cytokine and Catecholamine Levels at Different Points of Measurement
Parameter
Point of Measurement
T1 T2 T3 T4
TNFα (< 8.1 ng/L) 1.4 ± 4.3 1.3 ± 3.7 3.9 ± 6.7
ABD 2.3 ± 5.4
BD
IL 6 (< 10 ng/L) 2.8 ± 7.7 4.9 ± 9.6 21.8 ± 17.6
ABD 26.2 ± 31.7
AB
IL 8 (< 63 ng/L) 14.9 ± 14.3 28.8 ± 38.8 44.7 ± 48.5
ABD 21.9 ± 29.6
BD
IL10 (< 10 ng/L) 0.8 ± 2.0 3.3 ± 7.2 41.3 ± 61.8
ABD 5.1 ± 8.6
AB
Adrenaline (165-468 pmol/L) 210.5 ± 203.5 145.2 ± 115.7 741.3 ± 648.5
ABD 277.3 ± 270.9
BD
Noradrenaline (1.09-1.63 pmol/L) 1.2 ± 0.9 1.1 ± 0.8 1.9 ± 1.1
ABD 2.6 ± 1.4
AB
Note.─
A = significant difference in comparison to, T1, 
B = significant difference in comparison to, T2, 
D = significant difference in comparison to T4,
TNF = tumor necrosis factor, IL = interleukin
Reference values are given in rectangular brackets. Significant differences in repeated measures ANOVA are indicated.
Table 4. Serum Chemistry Levels at Different Points of Measurement
Parameter
Point of Measurement
T1 T2 T3 T4
AST (5-17 U/L) 14.6 ± 100. .078.8 ± 55.5 162.8 ±131.5
A0 293.6 ± 259.6
ABC
ALT (5-23 U/L) 14.9 ± 9.70 44.4 ± 44 83.9 ± 63.80. 247.8 ± 234.8
ABC
GLDH (0.1-4.0 U/L) 04.9 ± 10.4 11.2 ± 17 30.2 ± 60.40. 152 ± 333.1
ABC
LDH (120-240 U/L) 168.8 ± 31.70. 259.2 ± 99.2 358.4 ± 160.20. 545.5 ± 522.2
ABC
PCHE (2000-7400 U/L) 4506.1 ± 1214.6 4061.4 ± 1393 4298 ± 1092.4 4281.6 ± 1321.
ABC
AP (40-190 U/L) 152 ± 105 00..144 ± 102.8 160 ± 104.6 180.4 ± 116.6
BCC
CK (10-80 U/L) 30.7 ± 20.8 .044.2 ± 38.6 109.9 ± 111.30. 218.1 ± 230.7
ABC
Lactate (1.1-1.8 mmol/L) 1.03 ± 0.36 O1.04 ± 0.32 1.34 ± 0.580. 1.56 ± 0.55
AB0
C
Note.─
A = significant difference in comparison to, T1, 
B = significant difference in comparison to, T2, 
C = significant difference in comparison to T3,
ALT = alanine aminotransferase, AP = alkaline phosphatase, AST = aspartate aminotransferase, CK = creatine kinase, GLDH = glutamate dehydrogenase,
LDH = lactate dehydrogenase, PCHE = pseudocholinesterase
Reference values are given in rectangular brackets. Significant differences in repeated measures ANOVA are indicated.mechanistic heating (9, 10, 15). A cryoablation associated
systemic inflammatory response syndrome (SIRS), with
high mortality (35%) (6, 9, 15), which was characterized
by multi-organ failure and coagulopathy, could not be
detected in any of these RFA patients, and has not yet
been reported after RFA. Therefore, the inflammatory and
stress response measured in this cohort of patients
undergoing percutaneous RFA of hepatic tumors has to be
interpreted in the context of procedural, anesthetic and
general considerations. 
Extent and time course of the increase in liver enzymes
and LDH are in agreement with previously published data,
reflecting the response to the liver injury caused by
ablation (16). Consistent with previous studies, we
observed a significant increase in body temperature during
and after percutaneous ‘hepatic RFA’ (17). However, a
clear correlation between applied energy and increase in
body temperature could not be established in this small
patient population. The hypothesis of local hepatic
hyperthermia, leading to systemic heating via intra-hepatic
blood flow, comparable to a ‘heat exchanger’ (17), is
supported by the transient normalization of body tempera-
ture measured immediately after the procedure. However,
differences in tumor location and vascularization make it
impossible to predict the systemic warming effect from the
total amount of applied energy. Of note, no cooling
techniques were used in this study.
The liver is a significant source of cytokines, which are
produced in Kupffer cells (18-20). The release of cytokines
may be depending on several conditions including the
ablation technique and type of anesthesia. In a rat model,
Chapman et al. (21) described a significantly higher
increase in TNFα at 24 hrs after performing hepatic
cryoablation when compared to RFA-treated animals.
Jansen et al. (22) demonstrated that systemic inflammation
induced by RFA or open partial liver resection are of the
same moderate magnitude and not as exaggerated as
frequently observed after cryoablation. The moderate
inflammatory reaction observed in this study supports the
findings of Schell et al. (10), indicating that the course of
systemic inflammation after percutaneous RFA is typically
moderate. These differences may be explained by differ-
ences in the mechanism of cell destruction. Cryoablation
induces a rupture of the plasma membrane, resulting in a
dispersion of intact cellular structures into the space of
Disse and leading to a systemic spreading. RFA, in
contrast, induces the coagulative destruction of intra
cytoplasmatic structures and does not touch cellular
surface integrity. Moreover, RFA results in local vessel
occlusion, limiting the local and systemic spread of
proinflammatory cytokines.
Interestingly, cytokine release is known to be influenced
by the type of anesthesia and the ventilatory regimen.
There is a significant correlation between balanced inhala-
tional anesthesia and the increase of pro-inflammatory IL-
6. The increase of IL-6 with TIVA has been reported to be
markedly less when compared with the results observed in
this study (23, 24). Therefore, the pro-inflammatory effect
in this study effect is likely due to RFA. TIVA is also
known to induce a significant increase of anti-inflamma-
tory cytokines (25). The use of propofol and remifentanil
in this study might have caused an anti-inflammatory
effect, although both IL-6 and IL-10 activation were
present.
The notable stress response is likely to have been attenu-
ated by anesthesia. In previous investigations, maximum
levels of stress hormones have been measured not during
the surgical procedure, but immediately after termination
of general anesthesia. This was attributed to the onset of
postoperative pain, centralization, and shivering (26-29).
These factors also need to be considered in RFA. One
purpose of anesthesia is the modification of stress response
to avoid surplus endocrine reactions and to preserve the
compensatory mechanisms (26, 30). The mode of anesthe-
sia is relevant, as endocrine stress response varies in differ-
ent anesthetic regimens. It was found to be less attenuated
with TIVA, compared with inhalation anesthesia (31). In
this study, catecholamine levels were normal during the
procedure, but increased post-interventionally, indicating
that the stress response has been sufficiently suppressed
during the procedure. Interestingly, the time courses of
adrenaline and noradrenaline were different, peaking at
different times. It has been speculated that propofol attenu-
ates noradrenaline release (32, 33). This might have
affected the suppression of noradrenaline production in the
early post-interventional period, but not the first post-
interventional day. 
The study suffers several limitations. First, only a small
number of patients with a broad variety of hepatic
neoplasms were included in this explorative study.
Nevertheless, there were relevant effects on inflammatory
and stress response. Second, all procedures were
performed under general anesthesia and there is no data
on conscious sedation. Considering the effects on inflam-
matory and stress reaction, it has to be recognized that
general anesthesia per se is not known to induce inflamma-
tion, and stress reaction is lowest with TIVA. Thus, the
observed effects have to be considered to be due to the
ablation procedure. However, we can only speculate if the
results would be different in patients treated under
conscious sedation. Finally, the energy applied with the
RF-3000 system could only be estimated with incomplete
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In conclusion, RFA of hepatic malignancies causes
inflammatory and endocrine activation, similar to SIRS. In
choosing the best management strategy, one has to
consider that the extent of this response is extremely
variable and is modulated by additional factors such as the
type of anesthesia. As percutaneous RFA is often
employed in fragile patients, these systemic reactions have
to be taken into account when dealing with patients
susceptible to sepsis or multi-organ failure.
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